Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-29

Clinical Trial Update: Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial in previously untreated chronic lymphocytic leukemia compares fludarabine and cyclophosphamide with or without rituximab; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Fludarabine (Fludarabine)
  • Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2011-03-29